| Literature DB >> 28223816 |
Morongwe Annah Sekokotla1, Nandu Goswami2, Constance Rufaro Sewani-Rusike1, Jehu Erapu Iputo3, Benedicta Ngwenchi Nkeh-Chungag4.
Abstract
OBJECTIVE: Metabolic syndrome (MetS), defined as the clustering of three of five risk factors (hypertension, obesity, triglyceridemia, dyslipidemia and hyperglycemia), is being increasingly mentioned among children and adolescents despite there being no consensus on how it should be defined in this set of population. Furthermore, very few studies have focused on MetS in children and adolescents in sub-Saharan populations. This study, therefore, aimed at determining the prevalence of the MetS and contributing risk in adolescents living in Mthatha, South Africa. RESEARCH DESIGN AND METHODS: Four hundred and ten adolescents (age range: 13-18 years, both sexes) were recruited into this cross-sectional study. In addition to a lifestyle questionnaire being administered, anthropometric measurements (weight, height and waist circumferences) were carried out for each participant. Fasting venous blood was collected for lipid profile and blood glucose assessments. Blood pressure was also measured. MetS was assessed using appropriate diagnostic criteria for children and adolescents.Entities:
Keywords: adolescent health; metabolic syndrome; obesity; overweight
Year: 2017 PMID: 28223816 PMCID: PMC5304970 DOI: 10.2147/TCRM.S124291
Source DB: PubMed Journal: Ther Clin Risk Manag ISSN: 1176-6336 Impact factor: 2.423
Demographic data and biochemical parameters of participants by sex and body size
| Females | Males | |
|---|---|---|
| N | 255 | 116 |
| Age (years) | 15.2±0.1 | 15.3±0.1 |
| Body mass index (kg/m2) | 25.4±0.3 | 22.3±0.4 |
| Waist circumference (cm) | 78.1±0.7 | 74.0±1.0 |
| Serum glucose (mg/dL) | 70.2±1.9 | 68.7±3.3 |
| Total cholesterol (mg/dL) | 160.8±2.1 | 140.5±3.9 |
| Triglyceride (mg/dL) | 67.8±2.1 | 68.0±2.9 |
| Low-density lipoprotein cholesterol (mg/dL) | 89.9±1.6 | 78.7±1.8 |
| High-density lipoprotein cholesterol (mg/dL) | 60.3±0.8 | 51.9±1.0 |
Notes: Data are expressed as mean ± standard error of mean. Comparison between female or male;
P<0.01.
Individual risk factors for metabolic syndrome and prevalence of metabolic syndrome as defined by the presence of three of five known risk factors
| Risk factors for MetS | Females, n (%) | Males, n (%) |
|---|---|---|
| Body mass index ≥85th percentile | 121 (47.5) | 28 (24.1) |
| WC ≥80 cm (females) | 102 (40) | 9 (6.0) |
| WC ≥94 cm (males) | ||
| HT/pre-HT | 83 (32.6) | 38 (32.8) |
| High-density | 63 (24.7) | 44 (37.9) |
| lipoprotein ≤40th percentile | ||
| Trig ≥90th percentile | 21 (8.2) | 11 (9.5) |
| Serum glucose ≥100.8 mg/dL | 9 (3.5) | 8 (6.9) |
| Number of risk factors for MetS | ||
| Metabolic syndrome (≥3 risk factors) | 8 (3.1) | 7 (6.0) |
| Two risk factors | 51 (22.7) | 23 (19.8) |
| One risk factor | 101 (39.6) | 35 (30.2) |
| No risk factor | 95 (37.3) | 51 (44.0) |
Abbreviations: HT, hypertension; MetS, metabolic syndrome; WC, waist circumference; Trig, triglyceride.
Metabolic severity risk score or continuous metabolic syndrome risk score
| Females
| Males
| |||||
|---|---|---|---|---|---|---|
| Cohort | Lean | O/O | Cohort | Lean | O/O | |
| Body mass index | 1.2±0.05 | 0.62±0.05 | 1.9±0.04 | 0.7±0.01 | 0.32±0.07 | 1.8±0.13 |
| cMetS | −0.06±0.04 | −0.44±0.04 | 0.37±0.05 | −0.02±0.06 | −0.47±0.9 | 0.05±0.19 |
| MetS percentile | 51.8±1.4 | 37.5±3.3 | 62.8±1.6 | 48.9±2.3 | 34.6±2.4 | 52.4±6.2 |
| MetS ≥90th percentile | 12 (5.6%) | 0 | 12 (5.6%) | 6 (6.7%) | 2 (2.2%) | 4 (4.5%) |
Notes: MetS is defined as cMet score ≥90th percentile.
P<0.01;
indicates P-value for comparisons between sex cohorts;
P<0.01;
indicates comparisons between females and males in the same sex group. Data presented as mean ± standard error or n (%).
Abbreviations: cMet z score, continuous metabolic risk z score; MetS, metabolic syndrome; O/O, overweight/obesity.
Adjusted regression coefficients of continuous metabolic syndrome risk score expressed as percentile of various independent variables
| Coefficient of model | 95% confidence interval | ||
|---|---|---|---|
| Age | −2.29 | −2.97 to −1.61 | 0.001 |
| Body mass index (kg/m2) | 2.60 | 2.41 to 2.79 | 0.001 |
| Mean systolic blood pressure (mmHg) | 0.42 | 0.33 to 0.50 | 0.001 |
| Glucose (mg/dL) | 0.37 | 0.35 to 0.40 | 0.001 |
| Total cholesterol (mg/dL) | 0.70 | −0.78 to −63 | 0.001 |
| Triglyceride (mg/dL) | 0.11 | 0.08 to 0.15 | 0.001 |
| Non-high-density lipoprotein cholesterol | 0.70 | 0.62 to 0.78 | 0.001 |
| Constant (y-intercept) | −13.52 | −31.49 to 4.45 | 0.14 |
Note: The dependent variable here is percentile of the metabolic syndrome continuous scores.
Linear logistic regression analysis of the association between selected independent variables and the presence of metabolic syndrome as defined by cMetS score ≥90%
| Number of times/week | Odds ratio | 95% confidence interval | |
|---|---|---|---|
| Green vegetables | 0.8313651 | 0.451–1.53 | 0.553 |
| Dairy | 1.704895 | 0.930–3.13 | 0.085 |
| Fatty foods | 0.8891876 | 451–1.75 | 0.734 |
| Sweets | 1.063637 | 0.546–2.07 | 0.856 |
| Animal protein | 1.170858 | 0.615–2.23 | 0.631 |
| Nuts | 0.856 | 0.441–1.66 | 0.646 |
| Carbohydrates | 0.9758898 | 0.463–2.06 | 0.949 |
| Physical exercise | 0.4682099 | 0.226–0.98 | 0.041 |
Note: Presence of metabolic syndrome defined as cMetS score ≥90%.
Abbreviation: cMetS, continuous metabolic syndrome.